Unraveling the convoluted biological roles of type I interferons in infection and immunity: a way forward for therapeutics and vaccine design

被引:18
|
作者
Wijesundara, Danushka Kumara [1 ,2 ]
Xi, Yang [3 ]
Ranasinghe, Charani [2 ]
机构
[1] Univ Adelaide, Basil Hetzel Inst, Dept Surg, Virol Lab, Adelaide, SA, Australia
[2] Australian Natl Univ, John Curtin Sch Med Res, Mol Mucosal Vaccine Immunol Grp, Canberra, ACT, Australia
[3] Univ Queensland, UQ Sch Med, Translat Res Inst, Lung & Allergy Res Ctr, Woolloongabba, Qld, Australia
来源
FRONTIERS IN IMMUNOLOGY | 2014年 / 5卷
基金
英国医学研究理事会;
关键词
type I interferons; human immunodeficiency virus; IFN-epsilon; vaccine adjuvants; interferon immunity; PLASMACYTOID DENDRITIC CELLS; HUMAN-LEUKOCYTE INTERFERON; CD8; T-CELLS; VIRUS-INFECTION; NEGATIVE REGULATORS; ANTIVIRAL ACTIVITY; IL-10; PRODUCTION; FAMILY PROTEINS; HIV-INFECTION; MOUSE MODEL;
D O I
10.3389/fimmu.2014.00412
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It has been well-established that type I interferons (IFN-Is) have pleiotropic effects and play an early central role in the control of many acute viral infections. However, their pleiotropic effects are not always beneficial to the host and in fact several reports suggest that the induction of IFN-Is exacerbate disease outcomes against some bacterial and chronic viral infections. In this brief review, we probe into this mystery and try to develop answers based on past and recent studies evaluating the roles of IFN-Is in infection and immunity as this is vital for developing effective IFN-Is based therapeutics and vaccines. We also discuss the biological roles of an emerging IFN-I, namely IFN-epsilon, and discuss its potential use as a mucosal therapeutic and/or vaccine adjuvant. Overall, we anticipate the discussions generated in this review will provide new insights for better exploiting the biological functions of IFN-Is in developing efficacious therapeutics and vaccines in the future.
引用
收藏
页数:7
相关论文
共 18 条
  • [1] Opposing Roles of Type I Interferons in Cancer Immunity
    Boukhaled, Giselle M.
    Harding, Shane
    Brooks, David G.
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021, 2021, 16 : 167 - 198
  • [2] Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection
    Maja Travar
    Miroslav Petkovic
    Antonija Verhaz
    Archivum Immunologiae et Therapiae Experimentalis, 2016, 64 : 19 - 31
  • [3] Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection
    Travar, Maja
    Petkovic, Miroslav
    Verhaz, Antonija
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2016, 64 (01) : 19 - 31
  • [4] Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections
    Lin, Jian-Da
    Feng, Ningguo
    Sen, Adrish
    Balan, Murugabaskar
    Tseng, Hsiang-Chi
    McElrath, Constance
    Smirnov, Sergey V.
    Peng, Jianya
    Yasukawa, Linda L.
    Durbin, Russell K.
    Durbin, Joan E.
    Greenberg, Harry B.
    Kotenko, Sergei V.
    PLOS PATHOGENS, 2016, 12 (04)
  • [5] Role of type I and type III interferons in intestinal immunity to homologous and heterologous rotavirus infection
    Lin, Jian-Da
    Feng, Ningguo
    Sen, Adrish
    Man, Murugabaskar
    Tseng, Hsiang-Chi
    McElrath, Constance
    Durbin, Russell K.
    Greenberg, Harry B.
    Durbin, Joan E.
    Kotenko, Sergei V.
    CYTOKINE, 2015, 76 (01) : 87 - 87
  • [6] Type I Interferons: Distinct Biological Activities and Current Applications for Viral Infection
    Li, Shi-fang
    Gong, Mei-jiao
    Zhao, Fu-rong
    Shao, Jun-jun
    Xie, Yin-li
    Zhang, Yong-guang
    Chang, Hui-yun
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 51 (05) : 2377 - 2396
  • [7] Sendai virus infection induces efficient adaptive immunity independently of type I Interferons
    López, CB
    Yount, JS
    Hermesh, T
    Moran, TM
    JOURNAL OF VIROLOGY, 2006, 80 (09) : 4538 - 4545
  • [8] Route of Infection Determines the Impact of Type I Interferons on Innate Immunity to Listeria monocytogenes
    Kernbauer, Elisabeth
    Maier, Verena
    Rauch, Isabella
    Mueller, Mathias
    Decker, Thomas
    PLOS ONE, 2013, 8 (06):
  • [9] Distinct Roles of Type I and Type III Interferons during a Native Murine β Coronavirus Lung Infection
    Sharma, Lokesh
    Peng, Xiaohua
    Qing, Hua
    Hilliard, Brandon K.
    Kim, Jooyoung
    Swaminathan, Anush
    Tian, Justin
    Israni-Winger, Kavita
    Zhang, Cuiling
    Habet, Victoria
    Wang, Lin
    Gupta, Gayatri
    Tian, Xuefei
    Ma, Yina
    Shin, Hyeon-Jun
    Kim, Sang-Hun
    Kang, Min-Jong
    Ishibe, Shuta
    Young, Lawrence H.
    Kotenko, Sergei
    Compton, Susan
    Wilen, Craig B.
    Wang, Andrew
    Dela Cruz, Charles S.
    JOURNAL OF VIROLOGY, 2022, 96 (02)
  • [10] Respective roles of TLR, RIG-I and NLRP3 in influenza virus infection and immunity: impact on vaccine design
    Ichinohe, Takeshi
    EXPERT REVIEW OF VACCINES, 2010, 9 (11) : 1315 - 1324